CN106728667A - A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation - Google Patents
A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation Download PDFInfo
- Publication number
- CN106728667A CN106728667A CN201611099770.1A CN201611099770A CN106728667A CN 106728667 A CN106728667 A CN 106728667A CN 201611099770 A CN201611099770 A CN 201611099770A CN 106728667 A CN106728667 A CN 106728667A
- Authority
- CN
- China
- Prior art keywords
- parts
- chong
- fruit
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
Abstract
The present invention relates to a kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation, said composition includes following parts by weight of component:Cultivated land 20 ~ 38,12 ~ 25 parts of dogwood fruit, 12 ~ 24 parts of Chinese yam rhizome, 8 ~ 15 parts of moutan bark, 8 ~ 15 parts of rhizoma alismatis, 8 ~ 16 parts of Poria cocos, 10 ~ 24 parts of the fruit of glossy privet, 12 ~ 22 parts of Eclipta prostrata.All medicines share in side of the present invention, the effect of enriching yin and nourishing kidney, regulating thoroughfare and controlling vessel are played altogether, is clinically used for treating the proliferation of mammary gland of Chong and Ren channel disorder and inclined kidney-yin deficiency.
Description
Technical field
The present invention relates to Chinese medicine composition field, more particularly to a kind of Chinese medicine group for treating Chong and Ren channel disorder type mastoproliferation
Compound.
Background technology
Cyclomastopathy is commonly encountered disease and frequently-occurring disease, and the country reports its incidence of disease 10% or so, and is mainly in 30
~50 years old women.Doctor trained in Western medicine application gonadotherapy this disease, may further disturb the balance between the hormone of human body after, and
Increase the possibility of canceration.So typically not using them as routine administration, only in serious symptom, just consider application.In the traditional Chinese medical science
Medicine treats cyclomastopathy from entirety, and the differentiation of disease is combined with dialectical, can from many aspects, multi-angle set out, play adjustment interior
Secretion, enhancing immunity of organisms effect, curative effect reliability with curative effect is high, curative effect stabilization and the characteristics of few side effects, effectively change
The degree of danger of kind life in patients and reduction mammary gland carcinogenesis.
Traditional Chinese medicine thinks:The sea for qi and blood is appointed in punching, and upper honor is breast, lower behavior warp.Punching appoints the sea of blood in the leading and menses of kidney
In the presence of by Sheng Erman, it is gradually empty by overflowing by Man Eryi, gradually contained again by empty, with after first filling the characteristics of catharsis;Punching is appointed
Physiological change directly affect the change of breast and uterus, physiological change of the breast in the menstrual cycle show as it is premenstrual full and
The catharsis after.Premenstrual the moon blood is sufficient, and irritability is vigorous, and the qi and blood that punching is appointed is filled, and makes mammary gland that physiological hyperplasia to occur, after with
Menses leak, and irritability must relax, and punching appoints qi and blood to remain static, and make mammary gland switch to return to the past by breeding.
For the proliferation of mammary gland caused by Chong and Ren channel disorder, CHONG meridian being the blood pool is under the jurisdiction of liver kidney, the moon arteries and veins of the main the whole body of conception vessel, if
Natural endowment element is weak, and the sea of blood is hollow, or the impariment of the liver of being enraged, and liver loses bar and reaches, under disturb the sea of blood, or kidney deficiency with age, conception vessel is not solid, so that punching is appointed
Imbalance, ties and forms newborn addiction in newborn network.This kind of is more common in menopausal women.Caking size and pain in swollen breasts or secret anguish, breast
The symptoms such as pain significantly mitigate often in premenstrual obvious exacerbation after.Often with lustreless complexion, soreness of waist and knee, neurolysis, night sleeps not
Intoxicated, paramenia, the few color of amount is light, even Amenorrhea.Pale tongue with white fur, pulse condition is thin and delicate.
The content of the invention
The treatment Chong and Ren channel disorder type breast that the technical problems to be solved by the invention are to provide a kind of effect is significant, treat both principal and secondary aspect of disease
The Chinese medicine composition of gland hyperplasia.
In order to solve the above technical problems, the present invention provides a kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation,
It is characterized in that:Said composition includes following parts by weight of component:
Cultivated land 20 ~ 38,12 ~ 25 parts of dogwood fruit, 12 ~ 24 parts of Chinese yam rhizome, 8 ~ 15 parts of moutan bark, 8 ~ 15 parts of rhizoma alismatis, 8 ~ 16 parts of Poria cocos,
10 ~ 24 parts of the fruit of glossy privet, 12 ~ 22 parts of Eclipta prostrata.
The composition also includes following parts by weight of component:
9 ~ 12 parts of corydalis tuber, 9 ~ 12 parts of Fructus meliae toosendan, 6 ~ 12 parts of frankincense, 6 ~ 9 parts of myrrh.
The composition also includes following parts by weight of component:
6 ~ 9 parts of semen brassicae, 10 ~ 15 parts of kelp, 15 ~ 30 parts of raw oyster, 10 ~ 15 parts of Snakegourd Fruit.
The composition also includes following parts by weight of component:
6 ~ 12 parts of moutan bark, 9 ~ 12 parts of cape jasmine, 10 ~ 20 parts of the fruit of glossy privet, 10 ~ 20 parts of Eclipta prostrata.
Cultivated land enriching yin and nourishing kidney, replenishing essence life marrow in side of the present invention, the monarch drug in a prescription in the side of being;Dogwood fruit nourishing the liver and kidney, Chinese yam is mended
Spleen QI invigorating, the fruit of glossy privet and Eclipta prostrata enriching yin are tonified the liver and kidney, and are ministerial drug.Rhizoma alismatis lets out kidney dampness removing, and it is greasy to prevent cultivated land from excessively growing;It is red
Skin can clearing liver fire, while the astriction of dogwood fruit can be restricted;The light spleen that oozes of Poria cocos is wet, helps Chinese yam rhizome invigorating the spleen and stomach,
Afterwards three herbal medicines be cathartic, rush down it is wet turbid, put down its inclined Sheng, be adjutant.All medicines share, the effect of enriching yin and nourishing kidney, regulating thoroughfare and controlling vessel are played altogether.
Indication:Enriching yin and nourishing kidney, regulating thoroughfare and controlling vessel, clinically increase for treating the mammary gland of Chong and Ren channel disorder and inclined kidney-yin deficiency
It is raw.
Usage and dosage:It is decocted in water for oral dose, one portion per day, at twice decoction.Take to menstrual onset within premenstrual 15 days.
"Sini San":
The obvious person of breast pain, choosing plus corydalis tuber, Fructus meliae toosendan, frankincense and myrrh, corydalis tuber is promoting blood circulation and removing blood stasis, promoting qi circulation and relieving pain, melia toosendan
Sub- catharsis liver heat, Xie Yu analgesics, frankincense and not have medicine phases 5 be use, in the logical internal organs of a surname, the key medicine of circulation channels and collaterals, with square foundation when
Return etc. and to match, qi and blood is taken into account, takes and knowingly follow the example of a wrongdoer victory.
The tough hard person of lump in breast, choosing plus semen brassicae, kelp, raw oyster and melon wither, semen brassicae its property wanders away, can dissipating bind disappear
Swollen, kelp and raw oyster softening and resolving hard mass, melon wither mass dissipating and swelling eliminating, coordinate the square foundation treatment tough hard symptom of lump.
Nipple discharge person, choosing plus moutan bark, cape jasmine, the fruit of glossy privet and Eclipta prostrata, moutan bark and cape jasmine removing pattogenic heat from the blood and toxic material from the body, the fruit of glossy privet
There is liver and kidney benefiting, tonifying yin blood effect with Eclipta prostrata, coordinate square foundation treatment nipple discharge symptom.
The present invention has advantages below compared with prior art:
1st, compatibility of the present invention is reasonable, with effect is significant, the curative effect treated both principal and secondary aspect of disease.
2nd, in side of the present invention Chinese yam rhizome, Poria cocos are medicine-food two-purpose material, and moutan bark, the fruit of glossy privet, cultivated land and Eclipta prostrata are
Conventional health care Chinese medicine, other rhizoma alismatis, dogwood fruit are the conventional medicinal material of middle medical circles, it is ensured that the security of prescription.
3rd, clinical data:My section office are with reference to the 8th meeting of Chinese TCM surgery mastosis Professional Committee of association in 2002
The standard for passing through(Refer to hereinafter), by outpatient service proliferation of mammary gland patient in March, 2015 to the one-year age of in March, 2016, wherein entirely
Portion women, the age includes cyclomastopathy 120 within 30-52 Sui, altogether, and wherein classification therapy belongs to Chong and Ren channel disorder type 30;
Daily 1 dose of decocting, premenstrual 15 days clothes to menstrual onset.Control group 38, uses asparagine 0.25g, vitamin E, 100mg, often
3 oral, TAM 10mg of bu, 1 tablet once, daily 2 times.With 4 months.Total effective rate is respectively 97.5%, 85.2% (P<
0.001)。
Specific embodiment
Embodiment 1
Cultivated land 20g, dogwood fruit 12g, Chinese yam rhizome 12g, moutan bark 9g, rhizoma alismatis 8g, Poria cocos l0g, fruit of glossy privet 10g, Eclipta prostrata 12g.
Each material medicine can buy from common pharmacy in the present invention, and medicine source is enriched, and affordable, its specification meets state
Family's medical standards.
For the unit of weighing used by each material medicine in embodiment, use here conventional gram during pharmaceutical drug taking, when
So, if if batch is prepared, being all possible with unit of weights such as kilogram, pounds, as long as it is each in meeting prescription of the present invention
Number relation between material medicine does not just do considered critical.
Embodiment 2
Cultivated land 25g, dogwood fruit 15g, Chinese yam rhizome 15g, moutan bark l0g, rhizoma alismatis 10g, Poria cocos l0g, fruit of glossy privet 15g, Eclipta prostrata
15g。
Embodiment 3
Cultivated land 30g, dogwood fruit 18g, Chinese yam rhizome 17g, moutan bark 12g, rhizoma alismatis 12g, Poria cocos 14g, fruit of glossy privet 19g, Eclipta prostrata
18g。
Embodiment 4
Cultivated land 38g, dogwood fruit 25g, Chinese yam rhizome 24g, moutan bark 15g, rhizoma alismatis 15g, Poria cocos 16g, fruit of glossy privet 24g, Eclipta prostrata
22g。
Embodiment 5
Cultivated land 25g, dogwood fruit 12g, Chinese yam rhizome 15g, moutan bark 12g, rhizoma alismatis 10g, Poria cocos l0g, fruit of glossy privet 15g, Eclipta prostrata
14g, corydalis tuber 9g, Fructus meliae toosendan 9g, frankincense 10g, myrrh 7g.
Embodiment 6
Cultivated land 35g, dogwood fruit 22g, Chinese yam rhizome 16g, moutan bark 14g, rhizoma alismatis 12g, Poria cocos 14g, fruit of glossy privet 20g, Eclipta prostrata
18g, corydalis tuber 8g, Fructus meliae toosendan 12g, frankincense 12g, myrrh 9g.
Embodiment 7
Cultivated land 27g, dogwood fruit 20g, Chinese yam rhizome 18g, moutan bark 10g, rhizoma alismatis 10g, Poria cocos 14g, fruit of glossy privet 15g, Eclipta prostrata
15g, semen brassicae 6g, kelp 11g, raw oyster 18g, melon wither 13g.
Embodiment 8
Cultivated land 36g, dogwood fruit 25g, Chinese yam rhizome 23g, moutan bark 15g, rhizoma alismatis 15g, Poria cocos 16g, fruit of glossy privet 22g, Eclipta prostrata
22g, semen brassicae 9g, kelp 14g, raw oyster 28g, melon wither 14g.
Embodiment 9
Cultivated land 20g, dogwood fruit 12g, Chinese yam rhizome 12g, moutan bark 9g, rhizoma alismatis 8g, Poria cocos l0g, fruit of glossy privet 10g, Eclipta prostrata 12g,
Moutan bark 8g, cape jasmine 12g, fruit of glossy privet 13g, Eclipta prostrata 15g.
Embodiment 10
Cultivated land 28g, dogwood fruit 18g, Chinese yam rhizome 20g, moutan bark 13g, rhizoma alismatis 15g, Poria cocos 16g, fruit of glossy privet 19g, Eclipta prostrata
20g, moutan bark 12g, cape jasmine 12g, fruit of glossy privet 17g, Eclipta prostrata 18g.
The relevant treat-and-release situation of the present invention is as follows:
The standard that the 8th meeting of Chinese TCM surgery mastosis Professional Committee of association in 2002 passes through:
(1)Primary symptom:
1. breast pain symptom is lighter, or without pain;
2. soreness and weakness of waist and knees or with heel pain:
3. the confusion of the menstrual cycle, amount less or number of days of passing through it is of short duration or it is dripping not to the utmost, or amenorrhoea.
(2)Secondary disease:
1. women above middle age:
2. dizziness and tinnitus;
3. tongue nature is light, and thin white fur of tongue, arteries and veins is thin.
CM syndrome differentiation criterion:Tool 2 primary symptoms+2 time disease.
The relevant treat-and-release situation typical case of the present invention is as follows:
Patient Xing, female, 46 years old.The left mucinous cystadenoma of ovary operation of cause in 5 years, private prosecution right breast distending pain over nearly 3 years rises
It is generally to aggravate in menstrual period at the beginning of disease, preceding doctor is once failed to respond to any medical treatment with dispersing stagnated hepatoqi, product promoting blood circulation and removing blood stasis.It takes ease pill, newborn addiction throughout the year
The medicine such as disappear, weight when light during symptom.The recent self-induction breast swollen exacerbation of weight, that touches has block in rope strip, and color ultrasound shows double cyclomastopathies.
It is the proliferation of mammary gland to examine.Inspection blood:AFP<20, CEA6.6, CA5019, CA15-3 345ur<L, CA12-5
64ur/L.Tongue is red, fat, and arteries and veins is thin.
Cultivated land 24g, dogwood fruit 15g, Chinese yam rhizome 15g, moutan bark l0g, rhizoma alismatis 10g, Poria cocos l0g, fruit of glossy privet 15g, non-irrigated lotus
Careless 15g.Corydalis tuber 10g, Fructus meliae toosendan 10g, frankincense 6g, myrrh 9g.7 doses, it is decocted in water for oral dose.
Further consultation:April 11 nineteen ninety-five.Mammary gland pain does not substantially mitigate after medicine, tubercle sense that the left breast of physical examination is slight, not and lump.
Multiple blood examination:CA50<5, CA15-3 7.0, CA12-5 9.1ur/L, in normal range (NR).
Cultivated land 24g, dogwood fruit 15g, Chinese yam rhizome 15g, moutan bark l0g, rhizoma alismatis 10g, Poria cocos l0g, fruit of glossy privet 15g, non-irrigated lotus
Careless 15g.Frankincense 6g, myrrh 9g.5 doses, it is decocted in water for oral dose.
Follow-up is not recurred for 1 year.
Technical scheme provided by the present invention is described in detail above.Specific case used herein is to this hair
Bright principle and implementation method is set forth, the explanation of above example be only intended to help understand the method for the present invention and its
Core concept.It should be pointed out that for those skilled in the art, not departing from the premise of the principle of the invention
Under, some improvement and modification can also be carried out to the present invention, these are improved and modification also falls into the protection of the claims in the present invention
In the range of.
Claims (4)
1. a kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation, it is characterised in that:Said composition includes following weight
Part component:
Cultivated land 20 ~ 38,12 ~ 25 parts of dogwood fruit, 12 ~ 24 parts of Chinese yam rhizome, 8 ~ 15 parts of moutan bark, 8 ~ 15 parts of rhizoma alismatis, 8 ~ 16 parts of Poria cocos,
10 ~ 24 parts of the fruit of glossy privet, 12 ~ 22 parts of Eclipta prostrata.
2. the Chinese medicine composition of Chong and Ren channel disorder type mastoproliferation is treated as claimed in claim 1, it is characterised in that:The combination
Thing also includes following parts by weight of component:
9 ~ 12 parts of corydalis tuber, 9 ~ 12 parts of Fructus meliae toosendan, 6 ~ 12 parts of frankincense, 6 ~ 9 parts of myrrh.
3. the Chinese medicine composition of Chong and Ren channel disorder type mastoproliferation is treated as claimed in claim 1, it is characterised in that:The combination
Thing also includes following parts by weight of component:
6 ~ 9 parts of semen brassicae, 10 ~ 15 parts of kelp, 15 ~ 30 parts of raw oyster, 10 ~ 15 parts of Snakegourd Fruit.
4. the Chinese medicine composition of Chong and Ren channel disorder type mastoproliferation is treated as claimed in claim 1, it is characterised in that:The combination
Thing also includes following parts by weight of component:
6 ~ 12 parts of moutan bark, 9 ~ 12 parts of cape jasmine, 10 ~ 20 parts of the fruit of glossy privet, 10 ~ 20 parts of Eclipta prostrata.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611099770.1A CN106728667A (en) | 2016-12-05 | 2016-12-05 | A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611099770.1A CN106728667A (en) | 2016-12-05 | 2016-12-05 | A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106728667A true CN106728667A (en) | 2017-05-31 |
Family
ID=58884177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611099770.1A Pending CN106728667A (en) | 2016-12-05 | 2016-12-05 | A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106728667A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113117002A (en) * | 2021-05-31 | 2021-07-16 | 兴安界首骨伤医院有限公司 | Dizhi rehmannia pills and preparation method thereof |
CN114377076A (en) * | 2021-02-09 | 2022-04-22 | 山东新时代药业有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating hyperplasia of mammary glands |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102379940A (en) * | 2010-09-04 | 2012-03-21 | 荣成市新技术应用研究所 | Chinese medicinal composition for treating hyperplasia of mammary glands |
CN104826016A (en) * | 2015-05-14 | 2015-08-12 | 成都市康飞药业有限公司 | Pharmaceutical composition for treating hyperplasia of mammary glands as well as preparation method and application thereof |
-
2016
- 2016-12-05 CN CN201611099770.1A patent/CN106728667A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102379940A (en) * | 2010-09-04 | 2012-03-21 | 荣成市新技术应用研究所 | Chinese medicinal composition for treating hyperplasia of mammary glands |
CN104826016A (en) * | 2015-05-14 | 2015-08-12 | 成都市康飞药业有限公司 | Pharmaceutical composition for treating hyperplasia of mammary glands as well as preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
刘晓雁等: "乳腺增生病中医临床诊疗方案规范化研究初探", 《第十一届全国中医及中西医结合乳腺病学术会议论文集》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114377076A (en) * | 2021-02-09 | 2022-04-22 | 山东新时代药业有限公司 | Application of traditional Chinese medicine composition in preparation of medicine for preventing and treating hyperplasia of mammary glands |
CN113117002A (en) * | 2021-05-31 | 2021-07-16 | 兴安界首骨伤医院有限公司 | Dizhi rehmannia pills and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100421724C (en) | Traditional medicine composition for treating chronic colitis and its preparing process | |
CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN103585378B (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
CN106728667A (en) | A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation | |
CN103495121A (en) | Mammary gland externally-applied medicament bag and manufacturing method thereof | |
CN103071060B (en) | Traditional Chinese medicine preparation for treating ankylosing spondylitis | |
CN105267674A (en) | Traditional Chinese medicine composition for treating acute mastitis | |
CN103157055B (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
CN106729370A (en) | A kind of Chinese medicine composition for treating Chong and Ren channel disorder type mastoproliferation | |
CN103816337A (en) | Traditional Chinese medicinal composition for treating delayed menstrual cycle | |
CN103386091A (en) | Rupikang traditional Chinese medicine composition and capsule preparation method | |
CN106214828A (en) | A kind of Chinese medicine of passage, nourishing blood and preparation method thereof | |
CN105748646A (en) | Traditional Chinese medicine composition for treating pain in neck or shoulders or waist or legs and preparation method thereof | |
CN105853930A (en) | Traditional Chinese medicine composition for treating depression | |
CN106620121A (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia caused by stagnation of qi due to depression of the liver | |
CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
CN104225016A (en) | Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis | |
CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN106692689A (en) | Traditional Chinese medicine composition for treating intermin-gled phlegm and blood stasis type mammary gland hyperplasia | |
CN106214977A (en) | A kind of treat dysphagic Chinese medicine composition | |
CN102091271A (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
CN105770478A (en) | Traditional Chinese medicine composition for treating bladder cancer | |
CN106620531A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
CN106177775A (en) | A kind of Chinese medicine composition treating hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |
|
WD01 | Invention patent application deemed withdrawn after publication |